Cutaneous Manifestations of COVID-19 in the Inpatient Setting

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic and Personal
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Dermatologic Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Recalcati S.
        Cutaneous manifestations in COVID-19: a first perspective.
        J Eur Acad Dermatol Venereol. 2020; 34: e212-e213
        • Guan W.J.
        • Liang W.H.
        • Zhao Y.
        • et al.
        Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis.
        Eur Respir J. 2020; 55
        • Askin O.
        • Altunkalem R.N.
        • Altinisik D.D.
        • et al.
        Cutaneous manifestations in hospitalized patients diagnosed as COVID-19.
        Dermatol Ther. 2020; : e13896
        • De Giorgi V.
        • Recalcati S.
        • Jia Z.
        • et al.
        Cutaneous manifestations related to coronavirus disease 2019 (COVID-19): A prospective study from China and Italy.
        J Am Acad Dermatol. 2020; 83: 674-675
        • Rekhtman S.
        • Tannenbaum R.
        • Strunk A.
        • et al.
        Eruptions and related clinical course among 296 hospitalized adults with confirmed COVID-19.
        J Am Acad Dermatol. 2021; 84: 946-952
        • Freeman E.E.
        • McMahon D.E.
        • Lipoff J.B.
        • et al.
        The spectrum of COVID-19-associated dermatologic manifestations: An international registry of 716 patients from 31 countries.
        J Am Acad Dermatol. 2020; 83: 1118-1129
        • Galvan Casas C.
        • Catala A.
        • Carretero Hernandez G.
        • et al.
        Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases.
        Br J Dermatol. 2020; 183: 71-77
        • Hubiche T.
        • Cardot-Leccia N.
        • Le Duff F.
        • et al.
        Clinical, laboratory, and interferon-alpha response characteristics of patients with chilblain-like lesions during the COVID-19 pandemic.
        JAMA Dermatol. 2021; 157: 202-206
        • Magro C.M.
        • Mulvey J.J.
        • Laurence J.
        • et al.
        Docked severe acute respiratory syndrome coronavirus 2 proteins within the cutaneous and subcutaneous microvasculature and their role in the pathogenesis of severe coronavirus disease 2019.
        Hum Pathol. 2020; 106: 106-116
        • Carvelli J.
        • Demaria O.
        • Vely F.
        • et al.
        Association of COVID-19 inflammation with activation of the C5a-C5aR1 axis.
        Nature. 2020; 588: 146-150
        • Li M.Y.
        • Li L.
        • Zhang Y.
        • et al.
        Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues.
        Infect Dis Poverty. 2020; 9: 45
        • Magro C.
        • Mulvey J.J.
        • Berlin D.
        • et al.
        Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases.
        Transl Res. 2020; 220: 1-13
        • Magro C.
        • Mulvey J.J.
        • Laurence J.
        • et al.
        The differing pathophysiologies that underlie COVID-19 associated perniosis and thrombotic retiform purpura: a case series.
        Br J Dermatol. 2021; 184: 141-150
        • Suchonwanit P.
        • Leerunyakul K.
        • Kositkuljorn C.
        Cutaneous manifestations in COVID-19: Lessons learned from current evidence.
        J Am Acad Dermatol. 2020; 83: e57-e60
        • Abou-Ismail M.Y.
        • Diamond A.
        • Kapoor S.
        • et al.
        The hypercoagulable state in COVID-19: Incidence, pathophysiology, and management.
        Thromb Res. 2020; 194: 101-115
        • Georgesen C.
        • Fox L.P.
        • Harp J.
        Retiform purpura: A diagnostic approach.
        J Am Acad Dermatol. 2020; 82: 783-796
        • Manalo I.F.
        • Smith M.K.
        • Cheeley J.
        • et al.
        A dermatologic manifestation of COVID-19: Transient livedo reticularis.
        J Am Acad Dermatol. 2020; 83: 700
        • Verheyden M.
        • Grosber M.
        • Gutermuth J.
        • et al.
        Relapsing symmetric livedo reticularis in a patient with COVID-19 infection.
        J Eur Acad Dermatol Venereol. 2020; 34: e684-e686
        • Llamas-Velasco M.
        • Munoz-Hernandez P.
        • Lazaro-Gonzalez J.
        • et al.
        Thrombotic occlusive vasculopathy in a skin biopsy from a livedoid lesion of a patient with COVID-19.
        Br J Dermatol. 2020; 183: 591-593
        • Droesch C.
        • Do M.H.
        • DeSancho M.
        • et al.
        Livedoid and purpuric skin eruptions associated with coagulopathy in severe COVID-19.
        JAMA Dermatol. 2020; 156: 1-3
        • Zhang Y.
        • Cao W.
        • Xiao M.
        • et al.
        [Clinical and coagulation characteristics in 7 patients with critical COVID-2019 pneumonia and acro-ischemia].
        Zhonghua Xue Ye Xue Za Zhi. 2020; 41: 302-307
        • Zhang Y.
        • Xiao M.
        • Zhang S.
        • et al.
        Coagulopathy and antiphospholipid antibodies in patients with Covid-19.
        N Engl J Med. 2020; 382: e38
        • Novara E.
        • Molinaro E.
        • Benedetti I.
        • et al.
        Severe acute dried gangrene in COVID-19 infection: a case report.
        Eur Rev Med Pharmacol Sci. 2020; 24: 5769-5771
        • Tang N.
        • Li D.
        • Wang X.
        • et al.
        Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia.
        J Thromb Haemost. 2020; 18: 844-847
        • Uthman I.W.
        • Gharavi A.E.
        Viral infections and antiphospholipid antibodies.
        Semin Arthritis Rheum. 2002; 31: 256-263
        • Karagounis T.K.
        • Shaw K.S.
        • Caplan A.
        • et al.
        Acrofacial purpura and necrotic ulcerations in COVID-19: a case series from New York City.
        Int J Dermatol. 2020; 59: 1419-1422
        • Le M.Q.
        • Rosales R.
        • Shapiro L.T.
        • et al.
        The down side of prone positioning: the case of a coronavirus 2019 survivor.
        Am J Phys Med Rehabil. 2020; 99: 870-872
        • Bosch-Amate X.
        • Giavedoni P.
        • Podlipnik S.
        • et al.
        Retiform purpura as a dermatological sign of coronavirus disease 2019 (COVID-19) coagulopathy.
        J Eur Acad Dermatol Venereol. 2020; 34: e548-e549
        • Tang N.
        • Bai H.
        • Chen X.
        • et al.
        Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy.
        J Thromb Haemost. 2020; 18: 1094-1099
        • Chowdhury J.F.
        • Moores L.K.
        • Connors J.M.
        Anticoagulation in hospitalized patients with Covid-19.
        N Engl J Med. 2020; 383: 1675-1678
        • Foley J.H.
        Examining coagulation-complement crosstalk: complement activation and thrombosis.
        Thromb Res. 2016; 141: S50-S54
        • Castelnovo L.
        • Capelli F.
        • Tamburello A.
        • et al.
        Symmetric cutaneous vasculitis in COVID-19 pneumonia.
        J Eur Acad Dermatol Venereol. 2020; 34: e362-e363
        • Young S.
        • Narang J.
        • Kumar S.
        • et al.
        Large sacral/buttocks ulcerations in the setting of coagulopathy: A case series establishing the skin as a target organ of significant damage and potential morbidity in patients with severe COVID-19.
        Int Wound J. 2020; 17: 2033-2037
        • Riphagen S.
        • Gomez X.
        • Gonzalez-Martinez C.
        • et al.
        Hyperinflammatory shock in children during COVID-19 pandemic.
        Lancet. 2020; 395: 1607-1608
        • Prevention CfDCa
        Multisystem inflammatory syndrome in children (MIS-C) associated with coronavirus disease 2019 (COVID-19).
        (Available at:) (Accessed December 14, 2020)
        • Belhadjer Z.
        • Meot M.
        • Bajolle F.
        • et al.
        Acute heart failure in multisystem inflammatory syndrome in children in the context of global SARS-CoV-2 pandemic.
        Circulation. 2020; 142: 429-436
        • Feldstein L.R.
        • Rose E.B.
        • Horwitz S.M.
        • et al.
        Multisystem inflammatory syndrome in U.S. children and adolescents.
        N Engl J Med. 2020; 383: 334-346
        • Rodriguez-Gonzalez M.
        • Castellano-Martinez A.
        • Cascales-Poyatos H.M.
        • et al.
        Cardiovascular impact of COVID-19 with a focus on children: A systematic review.
        World J Clin Cases. 2020; 8: 5250-5283
        • Kaushik A.
        • Gupta S.
        • Sood M.
        • et al.
        A systematic review of multisystem inflammatory syndrome in children associated with SARS-CoV-2 infection.
        Pediatr Infect Dis J. 2020; 39: e340-e346
        • Fernandes D.M.
        • Oliveira C.R.
        • Guerguis S.
        • et al.
        Severe acute respiratory syndrome coronavirus 2 clinical syndromes and predictors of disease severity in hospitalized children and youth.
        J Pediatr. 2021; 230: 23-31.e10
        • Henderson L.A.
        • Canna S.W.
        • Friedman K.G.
        • et al.
        American College of Rheumatology Clinical Guidance for Pediatric Patients with Multisystem Inflammatory Syndrome in Children (MIS-C) associated with SARS-CoV-2 and hyperinflammation in COVID-19. Version 2.
        Arthritis Rheumatol. 2021; 73: e13-e29
        • Belhadjer Z.
        • Auriau J.
        • Meot M.
        • et al.
        Addition of corticosteroids to immunoglobulins is associated with recovery of cardiac function in multi-inflammatory syndrome in children.
        Circulation. 2020; 142: 2282-2284
        • Tabaac S.
        • Kothari P.
        • Cassidy-Smith T.
        Multisystem inflammatory syndrome in children.
        J Emerg Med. 2021; 60: 531-535
        • Catala A.
        • Galvan-Casas C.
        • Carretero-Hernandez G.
        • et al.
        Maculopapular eruptions associated to COVID-19: A subanalysis of the COVID-Piel study.
        Dermatol Ther. 2020; : e14170
        • Daneshgaran G.
        • Dubin D.P.
        • Gould D.J.
        Cutaneous manifestations of COVID-19: An evidence-based review.
        Am J Clin Dermatol. 2020; 21: 627-639
        • Avellana Moreno R.
        • Estela Villa L.M.
        • Avellana Moreno V.
        • et al.
        Cutaneous manifestation of COVID-19 in images: a case report.
        J Eur Acad Dermatol Venereol. 2020; 34: e307-e309
        • Najarian D.J.
        Morbilliform exanthem associated with COVID-19.
        JAAD Case Rep. 2020; 6: 493-494
        • Ahouach B.
        • Harent S.
        • Ullmer A.
        • et al.
        Cutaneous lesions in a patient with COVID-19: are they related?.
        Br J Dermatol. 2020; 183: e31
        • Shehi E.
        • Chilimuri S.
        • Shin D.
        • et al.
        Microthrombi in skin biopsy of a patient with COVID-19.
        JAAD Case Rep. 2020; 6: 1327-1329
        • Reymundo A.
        • Fernaldez-Bernaldez A.
        • Reolid A.
        • et al.
        Clinical and histological characterization of late appearance maculopapular eruptions in association with the coronavirus disease 2019. A case series of seven patients.
        J Eur Acad Dermatol Venereol. 2020; 34: e755-e757
        • Rosell-Diaz A.M.
        • Mateos-Mayo A.
        • Nieto-Benito L.M.
        • et al.
        Exanthema and eosinophilia in COVID-19 patients: has viral infection a role in drug induced exanthemas?.
        J Eur Acad Dermatol Venereol. 2020; 34: e561-e563
        • Peroni A.
        • Colato C.
        • Schena D.
        • et al.
        Urticarial lesions: if not urticaria, what else? The differential diagnosis of urticaria: part I. Cutaneous diseases.
        J Am Acad Dermatol. 2010; 62 (quiz 555-546): 541-555
        • Lu S.
        • Lin J.
        • Zhang Z.
        • et al.
        Alert for non-respiratory symptoms of coronavirus disease 2019 patients in epidemic period: A case report of familial cluster with three asymptomatic COVID-19 patients.
        J Med Virol. 2021; 93: 518-521
        • Henry D.
        • Ackerman M.
        • Sancelme E.
        • et al.
        Urticarial eruption in COVID-19 infection.
        J Eur Acad Dermatol Venereol. 2020; 34: e244-e245
        • Hassan K.
        Urticaria and angioedema as a prodromal cutaneous manifestation of SARS-CoV-2 (COVID-19) infection.
        BMJ Case Rep. 2020; 13
        • Shanshal M.
        Low- dose systemic steroids, an emerging therapeutic option for COVID-19 related urticaria.
        J Dermatolog Treat. 2020; : 1-2
        • Quintana-Castanedo L.
        • Feito-Rodriguez M.
        • Valero-Lopez I.
        • et al.
        Urticarial exanthem as early diagnostic clue for COVID-19 infection.
        JAAD Case Rep. 2020; 6: 498-499
        • Amatore F.
        • Macagno N.
        • Mailhe M.
        • et al.
        SARS-CoV-2 infection presenting as a febrile rash.
        J Eur Acad Dermatol Venereol. 2020; 34: e304-e306
        • Lucas C.
        • Wong P.
        • Klein J.
        • et al.
        Longitudinal analyses reveal immunological misfiring in severe COVID-19.
        Nature. 2020; 584: 463-469
        • Criado P.R.
        • Abdalla B.M.Z.
        • de Assis I.C.
        • et al.
        Are the cutaneous manifestations during or due to SARS-CoV-2 infection/COVID-19 frequent or not? Revision of possible pathophysiologic mechanisms.
        Inflamm Res. 2020; 69: 745-756
        • Kaushik A.
        • Parsad D.
        • Kumaran M.S.
        Urticaria in the times of COVID-19.
        Dermatol Ther. 2020; : e13817
        • Fernandez-Nieto D.
        • Ortega-Quijano D.
        • Jimenez-Cauhe J.
        • et al.
        Clinical and histological characterization of vesicular COVID-19 rashes: a prospective study in a tertiary care hospital.
        Clin Exp Dermatol. 2020; 45: 872-875
        • Mahe A.
        • Birckel E.
        • Merklen C.
        • et al.
        Histology of skin lesions establishes that the vesicular rash associated with COVID-19 is not 'varicella-like'.
        J Eur Acad Dermatol Venereol. 2020; 34: e559-e561
        • Marzano A.V.
        • Genovese G.
        • Fabbrocini G.
        • et al.
        Varicella-like exanthem as a specific COVID-19-associated skin manifestation: Multicenter case series of 22 patients.
        J Am Acad Dermatol. 2020; 83: 280-285
        • Jimenez-Cauhe J.
        • Ortega-Quijano D.
        • Carretero-Barrio I.
        • et al.
        Erythema multiforme-like eruption in patients with COVID-19 infection: clinical and histological findings.
        Clin Exp Dermatol. 2020; 45: 892-895
        • Janah H.
        • Zinebi A.
        • Elbenaye J.
        Atypical erythema multiforme palmar plaques lesions due to Sars-Cov-2.
        J Eur Acad Dermatol Venereol. 2020; 34: e373-e375
        • Garcia-Gil M.F.
        • Garcia Garcia M.
        • Monte Serrano J.
        • et al.
        Acral purpuric lesions (erythema multiforme type) associated with thrombotic vasculopathy in a child during the COVID-19 pandemic.
        J Eur Acad Dermatol Venereol. 2020; 34: e443-e445
        • Khalili M.
        • Iranmanesh B.
        • Mohammadi S.
        • et al.
        Cutaneous and histopathological features of coronavirus disease 2019 in pediatrics: A review article.
        Dermatol Ther. 2020; : e14554
        • Labe P.
        • Ly A.
        • Sin C.
        • et al.
        Erythema multiforme and Kawasaki disease associated with COVID-19 infection in children.
        J Eur Acad Dermatol Venereol. 2020; 34: e539-e541
        • de Masson A.
        • Bouaziz J.D.
        • Sulimovic L.
        • et al.
        Chilblains is a common cutaneous finding during the COVID-19 pandemic: A retrospective nationwide study from France.
        J Am Acad Dermatol. 2020; 83: 667-670
        • Torrelo A.
        • Andina D.
        • Santonja C.
        • et al.
        Erythema multiforme-like lesions in children and COVID-19.
        Pediatr Dermatol. 2020; 37: 442-446
        • Cohen P.R.
        Sweet's syndrome--a comprehensive review of an acute febrile neutrophilic dermatosis.
        Orphanet J Rare Dis. 2007; 2: 34
        • Taskin B.
        • Vural S.
        • Altug E.
        • et al.
        Coronavirus 19 presenting with atypical Sweet's syndrome.
        J Eur Acad Dermatol Venereol. 2020; 34: e534-e535
        • Wang J.
        • Li Q.
        • Yin Y.
        • et al.
        Excessive neutrophils and neutrophil extracellular traps in COVID-19.
        Front Immunol. 2020; 11: 2063
        • Bomhof G.
        • Mutsaers P.
        • Leebeek F.W.G.
        • et al.
        COVID-19-associated immune thrombocytopenia.
        Br J Haematol. 2020; 190: e61-e64
        • Mahevas M.
        • Moulis G.
        • Andres E.
        • et al.
        Clinical characteristics, management and outcome of COVID-19-associated immune thrombocytopenia: a French multicentre series.
        Br J Haematol. 2020; 190: e224-e229
        • Murt A.
        • Eskazan A.E.
        • Yilmaz U.
        • et al.
        COVID-19 presenting with immune thrombocytopenia: A case report and review of the literature.
        J Med Virol. 2021; 93: 43-45
        • Zulfiqar A.A.
        • Lorenzo-Villalba N.
        • Hassler P.
        • et al.
        Immune thrombocytopenic purpura in a patient with Covid-19.
        N Engl J Med. 2020; 382: e43
        • Yang Y.
        • Zhao J.
        • Wu J.
        • et al.
        A rare case of immune thrombocytopenic purpura, secondary to COVID-19.
        J Med Virol. 2020; 92: 2358-2360
        • Xu P.
        • Zhou Q.
        • Xu J.
        Mechanism of thrombocytopenia in COVID-19 patients.
        Ann Hematol. 2020; 99: 1205-1208
        • Yang X.
        • Yang Q.
        • Wang Y.
        • et al.
        Thrombocytopenia and its association with mortality in patients with COVID-19.
        J Thromb Haemost. 2020; 18: 1469-1472